These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33260381)

  • 1. Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.
    Yim SK; Kim K; Chun S; Oh T; Jung W; Jung K; Yun CH
    Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors.
    Murray M; Zhang WV; Edwards RJ
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):388-395. PubMed ID: 29155491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.
    Manda VK; Avula B; Chittiboyina AG; Khan IA; Walker LA; Khan SI
    Xenobiotica; 2016; 46(2):117-25. PubMed ID: 26247834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes.
    Raunio H; Juvonen RO; Poso A; Lahtela-Kakkonen M; Rahnasto-Rilla M
    Drug Metab Lett; 2016; 10(1):56-64. PubMed ID: 26648056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin, sinensetin, and tangeretin are the main perpetrators in clementines provoking food-drug interactions in vitro.
    Weiss J; Gattuso G; Barreca D; Haefeli WE
    Food Chem; 2020 Jul; 319():126578. PubMed ID: 32187570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 binding studies of novel tacrine derivatives: Predicting the risk of hepatotoxicity.
    McEneny-King A; Osman W; Edginton AN; Rao PPN
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2443-2449. PubMed ID: 28400237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.
    Koe XF; Lim EL; Seah TC; Amanah A; Wahab HA; Adenan MI; Sulaiman SF; Tan ML
    Food Chem Toxicol; 2013 Oct; 60():98-108. PubMed ID: 23876819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
    Yeung JH; Or PM
    Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
    Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
    Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture.
    Dickmann LJ; Patel SK; Rock DA; Wienkers LC; Slatter JG
    Drug Metab Dispos; 2011 Aug; 39(8):1415-22. PubMed ID: 21555507
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 14. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human cytochrome P450 enzymes by Bacopa monnieri standardized extract and constituents.
    Ramasamy S; Kiew LV; Chung LY
    Molecules; 2014 Feb; 19(2):2588-601. PubMed ID: 24566323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes.
    Potęga A; Fedejko-Kap B; Mazerska Z
    Pharmacol Rep; 2016 Aug; 68(4):663-70. PubMed ID: 27110874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE; Ahern D; Scatina J; Kao J
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 Enzymes.
    Eng H; Obach RS
    Drug Metab Dispos; 2016 Aug; 44(8):1217-28. PubMed ID: 27271369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals.
    Usmani KA; Cho TM; Rose RL; Hodgson E
    Drug Metab Dispos; 2006 Sep; 34(9):1606-14. PubMed ID: 16790556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 inhibition activities of non-standardized botanical products.
    Abduraman MA; Mustafa NH; Yaacob NS; Amanah A; Tan ML
    J Ethnopharmacol; 2022 Oct; 296():115406. PubMed ID: 35659627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.